Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
55.10
+0.30 (0.55%)
At close: Aug 12, 2025, 4:00 PM
54.10
-1.00 (-1.81%)
After-hours: Aug 12, 2025, 7:10 PM EDT
Nuvei Employees
As of December 31, 2024, Guardant Health had 2,021 total employees, including 1,999 full-time and 22 part-time employees. The number of employees increased by 242 or 13.60% compared to the previous year.
Employees
2,021
Change (1Y)
242
Growth (1Y)
13.60%
Revenue / Employee
$410,118
Profits / Employee
-$204,759
Market Cap
6.87B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,021 | 242 | 13.60% |
| Dec 31, 2023 | 1,779 | -14 | -0.78% |
| Dec 31, 2022 | 1,793 | 420 | 30.59% |
| Dec 31, 2021 | 1,373 | 509 | 58.91% |
| Dec 31, 2020 | 864 | 242 | 38.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GH News
- 5 days ago - Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025 - Seeking Alpha
- 8 days ago - American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health Equity - Business Wire
- 12 days ago - Guardant Health to Participate in the Canaccord Genuity 45th Annual Growth Conference - Business Wire
- 12 days ago - Guardant Health Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Earnings - Benzinga
- 12 days ago - Guardant Health, Inc. (GH) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Guardant Health Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance - Business Wire
- 13 days ago - Guardant Health and James Van Der Beek Team Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+ - Business Wire
- 14 days ago - New RADIOHEAD Study Validates Use of Guardant Reveal Tissue-Free Monitoring for Earlier Detection of Immunotherapy Response in Advanced Cancer - Business Wire